Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Percutaneous left atrial appendage closure reduces cost of care independent of the institutional cumulative caseload in patients with non-valvular atrial fibrillation.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2022

Same author

Multiple culprit lesions in ST-segment elevation myocardial infarction with cardiogenic shock: a case of simultaneous thrombosis of two infarct-related arteries.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2022

Same author

Rehospitalization and actual management costs after percutaneous left atrial appendage closure: Facing the conundrum.

International journal of cardiology·2021

Same author

Deactivation of cardiovascular implantable electronic devices in patients nearing end of life : Reality or only recommendation?

Herz·2019

Same author

Inherited thrombophilia in unprovoked venous thromboembolism: Is non 'O' blood group an additional culprit in Indian patients?

Medical journal, Armed Forces India·2019

Same author

[Acute heart failure in a recreational sportswoman].

Der Radiologe·2019

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Administration of Δ⁹-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

[Positive influence on cardiovascular risk factor by blocking the endocannabinoid system].

T Chatterjee¹, A Ritz, H Ince

¹HerzZentrum Hirslanden Zentralschweiz, Hirslanden Klinik St. Anna, Luzern. tushar.chatterjee@hirslanden.ch

|July 3, 2008

Summary

Central adiposity is linked to cardiovascular risk. Rimonabant, a cannabinoid-1 receptor blocker, is being developed to treat obesity and related cardiometabolic risk factors.

Related Experiment Videos

Last Updated: Jul 4, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Administration of Δ⁹-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Area of Science:

Endocrinology
Cardiovascular Medicine
Pharmacology

Background:

Intra-abdominal fat (central adiposity) correlates strongly with cardiovascular risk.
Adipose tissue functions as an endocrine organ, secreting hormones and cytokines that affect appetite, metabolism, and atherosclerosis.
Cannabinoid-1 receptor (CB1) signaling plays a role in energy balance and metabolic processes.

Purpose of the Study:

To review the efficacy of rimonabant, a selective cannabinoid-1 receptor blocker.
To evaluate rimonabant's potential in managing obesity and related cardiometabolic risk factors.

Main Methods:

Review of preclinical and clinical studies on rimonabant.
Analysis of data regarding rimonabant's effects on body weight, metabolic parameters, and cardiovascular risk markers.

Main Results:

Rimonabant demonstrated efficacy in reducing body weight and improving metabolic profiles in clinical trials.
The drug targeted the endocannabinoid system to influence appetite and energy expenditure.
Observed effects on atherosclerosis markers warrant further investigation.

Conclusions:

Rimonabant represents a novel therapeutic approach for obesity and associated cardiometabolic conditions.
Selective CB1 receptor blockade shows promise in managing central adiposity and its complications.
Further research is needed to fully elucidate long-term safety and efficacy profiles.